Entheon Biomedical Corp. (ENTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0790
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Entheon Biomedical Market Cap
Entheon Biomedical has a market cap or net worth of $1.01 million as of February 12, 2026. Its market cap has increased by 131.70% in one year.
Market Cap
1.01M
Enterprise Value
729.31K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since November 12, 2020, Entheon Biomedical's market cap has decreased from 18.81M to 1.01M, a decrease of -94.65%. That is a compound annual growth rate of -43.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 1.01M | -11.58% |
| Dec 30, 2024 | 1.14M | 154.54% |
| Dec 29, 2023 | 447.43K | -48.76% |
| Dec 30, 2022 | 873.18K | -94.25% |
| Dec 31, 2021 | 15.18M | -55.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| International Stem Cell | 1.32M |
| Sigyn Therapeutics | 1.20M |
| Halberd | 1.16M |
| Evofem Biosciences | 1.14M |
| CERo Therapeutics Holdings | 1.14M |
| Emmaus Life Sciences | 1.08M |
| Protagenic Therapeutics | 944.67K |
| Lipella Pharmaceuticals | 878.42K |